These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32840972)

  • 1. How DNA medicines could transform treatment of glioblastoma multiforme.
    Skolnick J
    Am J Manag Care; 2020 Aug; 26(7 Spec No.):SP224-SP225. PubMed ID: 32840972
    [No Abstract]   [Full Text] [Related]  

  • 2. The concurrent effect of acyclovir and rosemary on glioblastoma cell culture.
    Özdemir MD; Göktürk D
    Cell Mol Biol (Noisy-le-grand); 2019 Mar; 65(3):66-71. PubMed ID: 30942157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SnapShot: glioblastoma multiforme.
    Kotliarova S; Fine HA
    Cancer Cell; 2012 May; 21(5):710-710.e1. PubMed ID: 22624719
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidermal growth factor receptor vaccination for glioblastoma multiforme.
    Komotar RJ; Starke RM; Connolly ES; Sisti MB
    Neurosurgery; 2011 Feb; 68(2):N20-1. PubMed ID: 21654573
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.
    Eramo A; Pallini R; Lotti F; Sette G; Patti M; Bartucci M; Ricci-Vitiani L; Signore M; Stassi G; Larocca LM; Crinò L; Peschle C; De Maria R
    Cancer Res; 2005 Dec; 65(24):11469-77. PubMed ID: 16357155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
    Li R; Chen X; You Y; Wang X; Liu Y; Hu Q; Yan W
    Oncotarget; 2015 Oct; 6(31):30968-74. PubMed ID: 26427041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma multiforme and the epidermal growth factor receptor.
    Friedman HS; Bigner DD
    N Engl J Med; 2005 Nov; 353(19):1997-9. PubMed ID: 16282174
    [No Abstract]   [Full Text] [Related]  

  • 9. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
    Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
    Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft.
    Friedman HS; Johnson SP; Dong Q; Schold SC; Rasheed BK; Bigner SH; Ali-Osman F; Dolan E; Colvin OM; Houghton P; Germain G; Drummond JT; Keir S; Marcelli S; Bigner DD; Modrich P
    Cancer Res; 1997 Jul; 57(14):2933-6. PubMed ID: 9230204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the absolute value of O(6)-methylguanine-DNA methyltransferase gene messenger RNA a prognostic factor, and does it predict the results of treatment of glioblastoma with temozolomide?
    Tanaka S; Akimoto J; Narita Y; Oka H; Tashiro T
    J Neurosurg; 2014 Oct; 121(4):818-26. PubMed ID: 25105699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of PD-L1 expression in glioblastoma multiforme.
    Heiland DH; Haaker G; Delev D; Mercas B; Masalha W; Heynckes S; Gäbelein A; Pfeifer D; Carro MS; Weyerbrock A; Prinz M; Schnell O
    Oncotarget; 2017 Jun; 8(26):42214-42225. PubMed ID: 28178682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods of resistance to epidermal growth factor receptor inhibition in glioblastoma multiforme.
    Komotar RJ; Starke RM; Connolly ES; Sisti MB
    Neurosurgery; 2012 Feb; 70(2):N13-4. PubMed ID: 22251981
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro split-dose recovery of glioblastoma multiforme.
    Taghian A; Gioioso D; Budach W; Suit H
    Radiat Res; 1993 Apr; 134(1):16-21. PubMed ID: 8386388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NF-κB signaling ablates the invasive phenotype of glioblastoma.
    Westhoff MA; Zhou S; Nonnenmacher L; Karpel-Massler G; Jennewein C; Schneider M; Halatsch ME; Carragher NO; Baumann B; Krause A; Simmet T; Bachem MG; Wirtz CR; Debatin KM
    Mol Cancer Res; 2013 Dec; 11(12):1611-23. PubMed ID: 24145173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characteristics and pathways of Avastin for the treatment of glioblastoma multiforme.
    Spasic M; Chow F; Tu C; Nagasawa DT; Yang I
    Neurosurg Clin N Am; 2012 Jul; 23(3):417-27. PubMed ID: 22748654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Instability of microsatellites in human gliomas.
    Dams E; Van de Kelft EJ; Martin JJ; Verlooy J; Willems PJ
    Cancer Res; 1995 Apr; 55(7):1547-9. PubMed ID: 7882363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme.
    Fujimoto M; Fults DW; Thomas GA; Nakamura Y; Heilbrun MP; White R; Story JL; Naylor SL; Kagan-Hallet KS; Sheridan PJ
    Genomics; 1989 Feb; 4(2):210-4. PubMed ID: 2544511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme.
    Ghasemi A; Fallah S; Ansari M
    Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.